Evotec (EVO)
(Delayed Data from NSDQ)
$3.71 USD
0.00 (0.00%)
Updated Aug 30, 2024 11:51 AM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for Evotec AG falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 846 | 792 | 731 | 572 | 500 |
Cost Of Goods | 656 | 608 | 552 | 429 | 351 |
Gross Profit | 189 | 183 | 179 | 144 | 149 |
Selling & Adminstrative & Depr. & Amort Expenses | 241 | 161 | 131 | 88 | 79 |
Income After Depreciation & Amortization | -51 | 22 | 49 | 55 | 70 |
Non-Operating Income | -36 | -170 | 243 | -16 | 2 |
Interest Expense | 0 | 14 | 11 | 10 | 8 |
Pretax Income | -87 | -162 | 280 | 29 | 63 |
Income Taxes | 4 | 23 | 25 | 22 | 22 |
Minority Interest | 0 | 0 | 0 | 0 | -1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -91 | -185 | 255 | 7 | 42 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -91 | -185 | 255 | 7 | 43 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 49 | 110 | 132 | 120 | 126 |
Depreciation & Amortization (Cash Flow) | 101 | 88 | 83 | 64 | 56 |
Income After Depreciation & Amortization | -51 | 22 | 49 | 55 | 70 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 312.60 | 304.58 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | 0.02 | 0.14 |
Diluted Net EPS (GAAP) | -0.25 | -0.52 | 0.77 | 0.02 | 0.14 |
Fiscal Year end for Evotec AG falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 196.13 | 226.61 | NA | 213.63 | 185.67 |
Cost Of Goods | 179.18 | 188.88 | NA | 172.46 | 135.16 |
Gross Profit | 16.95 | 37.74 | NA | 41.17 | 50.51 |
SG&A, R&D, and Dept/Amort Expenses | 129.60 | 57.50 | 0.00 | 54.43 | 90.08 |
Income After SG&A, R&D, and Dept/Amort Expenses | -112.65 | -19.76 | 0.00 | -13.26 | -39.57 |
Non-Operating Income | 0.16 | -9.31 | NA | -15.46 | 20.05 |
Interest Expense | 0.00 | 0.00 | NA | 3.83 | 2.77 |
Pretax Income | -112.49 | -29.08 | NA | -32.56 | -22.28 |
Income Taxes | -10.26 | -6.63 | NA | 9.84 | -6.01 |
Minority Interest | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Income From Cont. Operations | -102.23 | -22.44 | NA | -42.40 | -16.28 |
Extras & Discontinued Operations | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Net Income (GAAP) | -102.23 | -22.44 | NA | -42.40 | -16.28 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -1.15 | -0.26 | NA | -0.48 | -0.17 |